162 related articles for article (PubMed ID: 28271329)
1. Stabilization Improves Theranostic Properties of Lipiodol
Deschamps F; Farouil G; Gonzalez W; Robic C; Paci A; Mir LM; Tselikas L; de Baère T
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):907-913. PubMed ID: 28271329
[TBL] [Abstract][Full Text] [Related]
2. Parameters for Stable Water-in-Oil Lipiodol Emulsion for Liver Trans-Arterial Chemo-Eembolization.
Deschamps F; Moine L; Isoardo T; Tselikas L; Paci A; Mir LM; Huang N; Fattal E; de Baère T
Cardiovasc Intervent Radiol; 2017 Dec; 40(12):1927-1932. PubMed ID: 28770315
[TBL] [Abstract][Full Text] [Related]
3. Pickering-Emulsion for Liver Trans-Arterial Chemo-Embolization with Oxaliplatin.
Deschamps F; Harris KR; Moine L; Li W; Tselikas L; Isoardo T; Lewandowski RJ; Paci A; Huang N; de Baere T; Salem R; Larson AC
Cardiovasc Intervent Radiol; 2018 May; 41(5):781-788. PubMed ID: 29468287
[TBL] [Abstract][Full Text] [Related]
4. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Kwak K; Yu B; Mouli SK; Larson AC; Kim DH
J Vasc Interv Radiol; 2020 Oct; 31(10):1697-1705.e3. PubMed ID: 32773247
[TBL] [Abstract][Full Text] [Related]
5. [Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits].
Liu X; Luo XP; Cao WT; Deng H
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):611-6. PubMed ID: 23207156
[TBL] [Abstract][Full Text] [Related]
6. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
Choi JW; Cho HJ; Park JH; Baek SY; Chung JW; Kim DD; Kim HC
PLoS One; 2014; 9(12):e115898. PubMed ID: 25551760
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable Pickering emulsions of Lipiodol for liver trans-arterial chemo-embolization.
Deschamps F; Isoardo T; Denis S; Tsapis N; Tselikas L; Nicolas V; Paci A; Fattal E; de Baere T; Huang N; Moine L
Acta Biomater; 2019 Mar; 87():177-186. PubMed ID: 30708065
[TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model.
Yasui D; Yamane A; Itoh H; Kobayashi M; Kumita SI
PLoS One; 2020; 15(8):e0222553. PubMed ID: 32756561
[TBL] [Abstract][Full Text] [Related]
9. Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model.
van Breugel JMM; Geschwind JF; Mirpour S; Savic LJ; Zhang X; Duran R; Lin M; Miszczuk M; Liapi E; Chapiro J
Theranostics; 2019; 9(13):3674-3686. PubMed ID: 31281506
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model.
Gupta S; Wright KC; Ensor J; Van Pelt CS; Dixon KA; Kundra V
Cardiovasc Intervent Radiol; 2011 Oct; 34(5):1021-30. PubMed ID: 21479746
[TBL] [Abstract][Full Text] [Related]
11. [Transhepatic arterial embolization with superparamagnetic iron oxide and lipiodol for the treatment of VX2 tumor in rabbits].
Liang Q; Deng L; Feng Z; Liu X; Ding J; Hu P; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1248-1256. PubMed ID: 29187650
[TBL] [Abstract][Full Text] [Related]
12. Sustained-hepatic arterial infusion of oxaliplatin: pharmacokinetic advantages over hepatic arterial infusion using a preclinical animal tumour model.
Deschamps F; Tselikas L; Tasaki M; Motoyama S; Isoardo T; Ducreux M; Paunovic D; Moine L; de Baere T
Drug Deliv Transl Res; 2021 Oct; 11(5):2144-2150. PubMed ID: 33432522
[TBL] [Abstract][Full Text] [Related]
13. Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model Study.
Lee IJ; Lee M; Kim SJ; Kim YK; Won JY; Chung JW
J Vasc Interv Radiol; 2018 Aug; 29(8):1078-1084. PubMed ID: 29910164
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial embolization with 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor.
Yoon CJ; Chung JW; Park JH; Kim YI; Lee KH; Jeong JM; Paeng JC
J Vasc Interv Radiol; 2004 Oct; 15(10):1121-8. PubMed ID: 15466799
[TBL] [Abstract][Full Text] [Related]
15. Transarterial Infusion of iRGD-Modified ZrO
Xie Y; Qi X; Xu K; Meng X; Chen X; Wang F; Zhong H
J Vasc Interv Radiol; 2019 Dec; 30(12):2026-2035.e2. PubMed ID: 31590966
[TBL] [Abstract][Full Text] [Related]
16. Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
Kim GM; Kim MD; Kim do Y; Kim SH; Won JY; Park SI; Lee do Y; Shin W; Shin M
J Vasc Interv Radiol; 2016 Jul; 27(7):1086-92. PubMed ID: 27179404
[TBL] [Abstract][Full Text] [Related]
17. Synergism of wt-p53 and synthetic material in local nano-TAE gene therapy of hepatoma: comparison of four systems and the possible mechanism.
Li G; Kang W; Jin M; Zhang L; Zheng J; Jia K; Ma J; Liu T; Dang X; Yan Z; Gao Z; Xu J
BMC Cancer; 2019 Nov; 19(1):1126. PubMed ID: 31747895
[TBL] [Abstract][Full Text] [Related]
18. [Influence of As2O3-lipiodol emulsion via transarterial embolization on a VX2 liver tumor model in rabbits].
Zou Y; Guo CG; Xu SL; Peng ZY; Sun JH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 44(5):559-65. PubMed ID: 26713532
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of miriplatin-lipiodol suspension/emulsion using a VX2 liver tumor model.
Tomozawa Y; Nitta N; Ohta S; Otani H; Watanabe S; Sonoda A; Tsuchiya K; Nitta-Seko A; Takahashi M; Murata K
Jpn J Radiol; 2013 Oct; 31(10):662-7. PubMed ID: 23828788
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of novel formulations for transarterial chemoembolization: combining elements of Lipiodol emulsions with Drug-eluting Beads.
Caine M; Chung T; Kilpatrick H; Bascal Z; Willis S; Tang Y; de Baere T; Dreher M; Lewis A
Theranostics; 2019; 9(19):5626-5641. PubMed ID: 31534507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]